Clinical Trial Update: Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy of Ragweed-SPIRE for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Ragweed-SPIRE

Snippet

Sponsor: Circassia Limited | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED